Health & Wellness

Press Releases

Dr. Angela Alistar, National Leader in Gastrointestinal Cancer Research, to Speak at International Oncology Conference

0a1ff70873c63771b015_Dr._Angela_Alistar_2017.jpg
0a1ff70873c63771b015_Dr._Angela_Alistar_2017.jpg

Nationally renowned gastrointestinal (GI) cancer researcher Angela Alistar, MD, medical director of GI medical oncology at Morristown Medical Center, Atlantic Health System Cancer Care, has been invited to speak this week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics:  Discovery, Biology, and Clinical Applications.

The conference will be held in Philadelphia October 26-30, and is sponsored by the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC). It is considered the premier international meeting on novel cancer therapeutics. 

Dr. Alistar will speak on cancer metabolism and her pioneering study, published this summer in The Lancet Oncology, on CPI-613, an advanced, first-in-class drug that offers new hope for people with pancreatic cancer, one of the most difficult cancers to treat.  Her presentation will take place on October 28 at 4:30 p.m. ET, as part of a session on cancer metabolism chaired by Dr. Dimitrios Anastasiou from London’s Francis Crick Institute and Dr. W. Marston Lineham, from the NCI.

Sign Up for E-News

“It is truly a great honor to be invited to speak at this meeting, along with this stellar lineup of internationally renowned cancer researchers,” said Dr. Alistar.  “I look forward to sharing the promise my studies have shown, and to discussing future research plans.”

Dr. Alistar will serve as the Co-Principal Investigator with Dr. Philip Philip of Karmanos Cancer Institute on a planned multi-center Phase III study of CPI-613 in combination with modified FOLFIRINOX, a multidrug treatment for metastatic pancreatic cancer.  She has led four other clinical trials of CPI-613 for GI cancers, as well as studies of other novel oncology drugs, and research to determine disease processes and genetic factors in cancers of the gastrointestinal tract. 

Pancreatic cancer is the third leading cause of cancer-related death in the United States, with a five-year survival rate of just seven percent.  Fifty-three percent of patients are diagnosed with advanced disease. *

“We are extremely proud of the fact that Dr. Alistar has been invited to share her groundbreaking clinical research at this distinguished international symposium,” said Eric Whitman, MD, medical director, Atlantic Health System Cancer Care. “She has continued to design and develop innovative cancer treatments since joining Atlantic Medical Group Oncology. We are pleased that our growing team of outstanding and compassionate physicians is able to offer patients in this community access to the latest treatment advances through clinical trials across a broad range of cancer types."

Dr. Alistar joined Atlantic Health System earlier this year from the Wake Forest School of Medicine, where she led the GI oncology team, bringing cutting-edge treatments to patients. While there, she designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials. She was the Principal Investigator at Wake Forest University of the Precision Oncology study, which is poised to generate new hypotheses in the era of genomic driven clinical trials.

Study of Pancreatic Cancer Drug Provides Hope for Difficult-to-Treat Patients 

In the recent Lancet Oncology study, Dr. Alistar and colleagues conducted a Phase I clinical trial of CPI-613, in combination with a modified version of FOLFIRINOX, a current multidrug treatment regimen approved by the FDA for use in pancreatic cancer that has spread beyond the pancreas.  The trial was designed to determine the maximum tolerated dose of CPI-613 when used in combination with the modified FOLFIRINOX regimen in patients with Stage IV pancreatic cancer.  The study provided preliminary evidence of the drug combination’s efficacy, as well as demonstrating its safety and tolerability.

CPI-613, developed by New Jersey-based Rafael Pharmaceuticals, is a new type of medication known as an altered energy metabolism directed (AEMD) drug.  It is the first anticancer drug of its kind.  It is designed to disrupt the altered energy production pathways in cancer cells by selectively targeting a process in cell multiplication and survival. 

Background on Dr. Alistar

Dr. Alistar’s primary focus at Wake Forest School of Medicine was on immuno-oncology and its application in treatment of gastrointestinal cancers of the pancreas, colon, rectum, bile duct and esophagus, as well as in treating melanoma. Her clinical research projects involved active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genetics. An assistant professor of internal medicine at Wake Forest before joining Atlantic Health, she was also a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds Committee, and the Hepatobiliary Oncology Committee. She is a member of the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many other professional societies. She also serves as a member and advisor to several other health care organizations.  She is certified by the American Board of Internal Medicine, in both internal medicine and medical oncology.

Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania, and conducted her internship and residency at Englewood Hospital and Medical Center, where she was chief resident. After her residency, she was a fellow in hematology and medical oncology at Mount Sinai School of Medicine, Tisch Cancer Institute. She currently serves as an ad hoc reviewer for JAMA and was recently the recipient of the Danny Danielson Translational Innovation Award for her dedication to clinical research.

Dr. Alistar is a physician with Atlantic Hematology Oncology at the Carol G. Simon Cancer Center -Morristown Medical Center campus.  She is affiliated with Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Alistar can be reached at 973-971-7111

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Westfield

Springfield Acupuncturist Charged with Sexual Assault of Patient

February 24, 2018

SPRINGFIELD, NJ — A Springfield-based acupuncturist and was arrested and charged with sexually assaulting a patient, Acting Union County Prosecutor Michael A. Monahan and Springfield Police Chief John Cook jointly announced Friday.

 Edward Raskin, 55, of Chatham Township, Morris County, was charged with second-degree sexual assault and fourth-degree criminal sexual ...

Mayor Brindle’s Update

February 15, 2018

The following are highlights from the update that Mayor Shelley Brindle gave at Tuesday night’s town council meeting.

I first want to congratulate Nick Calello and David Went for their promotions to patrol officers in the Westfield Police Department. I’d also like to welcome and congratulate new Patrol Officer Fortunato Riga, who joins the police department this week upon his ...

Upcoming Events

Carousel_image_2e2e4830042112095f66_94f09724857a937db1ac_d6404e0a-7afd-4279-b56f-19b0f9b2138c

Sun, February 25, 10:00 AM

Camp Riverbend, Warren

Camp Riverbend Open House

Carousel_image_d28b11720ab931cdced4_hamantash_bake_2018

Sun, February 25, 11:30 AM

Union County Torah Center - Chabad, Westfield

Hamantash Bake at the Torah Center

Religions And Spirituality

Tue, February 27, 7:30 PM

Westfield

Westfield Board of Education Meeting

Education

Westfield Police Blotter: Man Steals 60 Pairs of Pants from Downtown Store & More

February 21, 2018

February 14, 2018 10:53 p.m.

Officers Gill and Weiss arrested Luis Murillo, age 30, of Rahway, NJ, for two outstanding warrants out of Westfield Municipal Court ($500) and Woodbridge Municipal Court ($500) pursuant to a motor vehicle stop in Scotch Plans Township. Subject was transported to headquarters, processed and released after posting requisite bail.

 

February 15, 2018 5:24 ...

Union County Hosts First LGBTQ Roundtable

February 24, 2018

On Tuesday, February 20, the Union County Board of Chosen Freeholders, through the Office of LGBTQ Services, hosted a roundtable with over 20 leading LGBTQ advocacy and ally organizations that serve Union County and New Jersey. Facilitated by Christian Fuscarino, Executive Director of Garden State Equality, more than 40 participants met to discuss LGBTQ-related programs, services, issues and ...

The Missing Moses

A seemingly dubious distinction belongs to this week’s Parshah, Tetzaveh (Exodus 27:20–30:10). It is the only reading in the Torah — from the first Parshah of the book of Exodus (in which he is born) until the end of the book of Numbers — where the name of Moses is not mentioned. Tetzaveh’s opening words are V’atah ...

‘Month of Hope’ at Wilson School

Inspired by the HOPE Week Initiative introduced in 2009 by the New York Yankees, Mr. Joseph Malanga, principal of Wilson School and a fan of the American League professional ballclub, declared January the “Month of Hope” at Wilson.

Malanga called on the school’s faculty Acts of Kindness Committee to choose the charitable organizations to be recipients of the weekly donation ...

AtlantiCast

AtlantiCast: Episode 12

On this week’s episode of AtlantiCast, decade of excellence makes headlines, as Atlantic Health’s place on Fortune Magazine’s 100 Best Companies to Work For List leads off the newest episode of AtlantiCast. Also on this week’s show, check out the newest “hybrid” operating room at Morristown Medical Center and find out how Atlantic Health is helping local ...

Would the Stock Market Affect Your Home Purchase?

"Fasten your seatbelts; it's going to be a bumpy night." ("All About Eve.") While most people misquote this as "It's going to be a bumpy ride," the actual quote works better for the movie. Bette Davis delivers this with the classic style that made her one of the most loved actresses of her generation.

Well for the stock market it’s been a wild bumpy ...

Good News in NJ for Veterans

Beginning in the 2017 tax year, New Jersey will give an additional $3,000 exemption for military veterans. You are eligible to claim this exemption NJ state income tax return if you are a military veteran who was honorably discharged or released under honorable circumstances from active duty in the Armed Forces of the United States on or before the last day of the tax year.

 

The ...

How to Talk with Kids About the Florida Shooting

February 13, 2018

The tragedy of the Florida school shooting is devastating, leaving 17 killed and 15 injured. Our children can easily identify with what occurred yesterday. It will be the topic of conversation today in schools everywhere. School administrators are doing all they can to provide support and guidance. The shootings affect children, teachers, and school personnel. The school shooting ...

Love Craft Beer But Hate the Tour? State Assembly Moves to Make it Easier for You to Belly Up to the Bar

Good news is a brew for New Jersey craft beer advocates. In February 2018, the New Jersey Assembly’s Agriculture and Natural Resources Committee paved the way for the introduction of Bill A2196, which would remove a current licensing rule requiring breweries and distilleries to provide a tour of their facilities before serving alcoholic beverages to consumers. Currently, breweries holding a ...

'What Stays' exposes family secrets and lies

‘What Stays’ exposes family secrets, resentment and lies

By Liz Keill

SUMMIT, NJ – In an original play by Laura Ekstrand and Jason Szamreta, the Dreamcatcher Repertory Theatre has provided an enlightening, funny and heart-felt view of family foibles.

Ekstrand has said that the germ of the play came from conversations with the ensemble members of the troupe, based on ...

Is FAANG Long in the Tooth?

Investors love to rally around a stock story. Today it’s all about the FAANG stocks. Facebook (FB), Amazon (AMZN), Apple (AAPL), Netflix (NFLX) and Google (GOOG) are a major reason why the S&P 500 rallied so much in 2017. Mr. Market is convinced the FAANGs are impervious to a sell-off. “Its different this time” is ringing loud and clear, but will the outcome really be that ...

Imagine a Chatham Toboggan Ride from the Top of Fairmount Avenue to Main Street

Did you know….
there was a time when Chatham kids could ice skate from downtown Chatham all the way to Florham Park? And that a toboggan ride could last from the top of Fairmount Avenue down to Main Street and beyond?

Those were the days!

This was back in the early to mid-1900s. The Passaic River meandered through grassy meadows and woods on the north side of Chatham. The marshy ...

Obituaries

Kathleen Marie Christian (nee Helmstetter), age 73 of Surf City, NJ, passed away peacefully at home ...
Read more

Nutley Police Make Arrest In Instagram School Threat Case

February 24, 2018

NUTLEY, NJ — An 18-year-old high school student has been charged with Third Degree False Public Alarm after an Instagram post led the Nutley school district to close schools last week.

Joseph Rafanello, a senior at Nutley High School, was arrested and taken to Essex County Jail.The arrest followed a full investigation by the police. The video at ...